Det er påvist, at anvendelsen af filgrastim- mobiliserede perifere blodstamceller reducerer graden og varigheden af trombocytopeni efter myelosuppresiv eller myeloablativ kemoterapi.
The use of filgrastim-mobilised PBPCs has been shown to reduce the depth and duration of thrombocytopenia following myelosuppressive or myeloablative chemotherapy.